Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €41.84 ($45.98) and traded as high ...

Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt and ...

Fresenius Medical Care Holdings Inc. prevailed at the First Circuit on Monday in a suit from MSP Recovery over alleged injuries linked to dialysis product GranuFlo.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The FDA is urging dialysis providers to conserve their supplies of blood flow lines, amid a shortage of the specialized ...

The US Food and Drug Administration (FDA) has added haemodialysis bloodlines to its medical device shortages list amid supply ...

THE HSE has been urged to fast-track the provision of a haemodialysis service in Ennis to reduce the travel time for Clare ...

Manufacturers of dialysis equipment adjust the designs of machines depending on the setting and the type of support that is ...

In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders; Fresenius Me ...